0001658367-16-000003.txt : 20160812 0001658367-16-000003.hdr.sgml : 20160812 20160812165805 ACCESSION NUMBER: 0001658367-16-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160812 DATE AS OF CHANGE: 20160812 EFFECTIVENESS DATE: 20160812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILIAD BIOTECHNOLOGIES, LLC CENTRAL INDEX KEY: 0001658367 IRS NUMBER: 454419429 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-268875 FILM NUMBER: 161828946 BUSINESS ADDRESS: STREET 1: 230 E 15TH STREET STREET 2: SUITE 1-A CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 917-913-8511 MAIL ADDRESS: STREET 1: 230 E 15TH STREET STREET 2: SUITE 1-A CITY: NEW YORK STATE: NY ZIP: 10003 D 1 primary_doc.xml X0707 D LIVE 0001658367 ILIAD BIOTECHNOLOGIES, LLC 230 E 15TH STREET SUITE 1-A NEW YORK NY NEW YORK 10003 917-913-8511 DELAWARE None None Limited Liability Company true 2012 KEITH RUBIN 230 East 15th Street Suite 1-A New York NY NEW YORK 10003 Executive Officer KEN SOLOVAY 230 East 15th Street Suite 1-A New York NY NEW YORK 10003 Executive Officer Biotechnology Decline to Disclose 06b false 2016-08-08 false true false 0 Walter C. Greenblatt 4723413 Walter Greenblatt & Associates 129291 430 Nassau Street Princeton NJ NEW JERSEY 08540 CT CONNECTICUT FL FLORIDA NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA false 5000000 545805 4454195 false 8 300000 true 0 Commission of $300,000 will be due if the offering amount is sold. 500000 true Portion of proceeds expected to be used to pay salaries of Messrs. Rubin and Solovay. false ILIAD BIOTECHNOLOGIES, LLC Keith Rubin Keith Rubin, MD Chief Executive Officer 2016-08-12